Previous Page  17 / 38 Next Page
Information
Show Menu
Previous Page 17 / 38 Next Page
Page Background

nal-IRI delivers irinotecan to the tumour microenvironment

protected within nanoliposomes

Drummond DC, et al. Cancer Res 2006;66:3271